Categories: News

Virbac : Declaration of the number of shares and voting rights 10/2022

 

 

 

 

 

 

 

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

 

 

 

Information on the total number of voting rights and of shares representing the share capital

(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité

des Marchés Financiers)

 

 

 

 

Quotation place: Euronext Paris

Compartiment A

ISIN code: FR0000031577

 

Date Total number of shares representing the share capital Total number of voting rights
October, 31 2022 8 458 000 Gross total of voting rights : 12 765 861
Net total* of voting rights : 12 752 425

 

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

 

 

 

 

 

 

 

VIRBAC: Shaping the future of animal health

NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP

Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com

Website: www.virbac.com

Attachment

Staff

Recent Posts

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global…

2 hours ago

LFTD Partners Inc. to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on April 1, 2024

JACKSONVILLE, FL / ACCESSWIRE / March 28, 2024 / LFTD Partners Inc. ("LFTD Partners" or…

2 hours ago

Unify Medical Announces Todd Rasmussen, MD, as Special Consultant for Its Military Initiatives

Unify Medical, Inc., a privately held, smart surgical visualization technology company, announced the appointment of…

5 hours ago

Empathic Podiatry Selects eClinicalWorks Cloud EHR, Revenue Cycle Management and Robotic Process Automation to Improve Efficiency

Texas-based specialty practice chooses eClinicalWorks Cloud EHR to increase automation, streamline workflows, and enhance patient…

8 hours ago

Rett Syndrome Research Trust selects PMD Solutions’ RespiraSense In Their Upcoming US-Based Biosensor Validation Study – VIBRANT

STOCKHOLM, SE / ACCESSWIRE / March 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Rett Syndrome…

8 hours ago

Health eCareers and AMSA Announce New Partnership

Connecting Medical Students and Employers to Research OpportunitiesNEW YORK, NY / ACCESSWIRE / March 28,…

8 hours ago